NeuFlex vs. Swanson metacarpophalangeal implants in treatment of RA .
This report has been verified
by one or more authors of the
original publication.
NeuFlex and Swanson Metacarpophalangeal Implants for Rheumatoid Arthritis: Prospective Randomized, Controlled Clinical Trial
J Hand Surg Am. 2010 Jan;35(1):44-5133 patients (age range 39-80) presenting with rheumatoid arthritis affecting (40 hands) were randomized to be managed with metacarpophalangeal joint (MCP) replacement with either NeuFlex or Swanson MCP implants. Both implants resulted in clinically satisfactory improvement in patients with rheumatoid arthritis; however, the NeuFlex implant offered better range of motion and the Swanson implant was liked better by patients for self reported function and aesthetics.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
